01 1Centaur Pharmaceuticals
01 1TIMOLOL MALEATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-05-08
Pay. Date : 2014-06-20
DMF Number : 23630
Submission : 2010-03-11
Status : Active
Type : II
20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TIMOLOL MALEATE USP, with a corresponding US DMF Number 23630.
Remarkably, this DMF maintains an Active status since its submission on March 11, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 08, 2015, and payment made on June 20, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
